Genevieve Steiner:

CBD for mild cognitive impairment and Alzheimer’s Disease

Associate Professor Genevieve Steiner is an NHMRC Emerging Leadership Fellow and Director of Research at the NICM Health Research Institute, Western Sydney University. Her cognitive neuroscience research spans the early detection, prevention, and treatment of cognitive decline in older people with the aim of reducing dementia risk and improving quality of life. A/Prof Steiner’s current focus is on testing novel therapeutics that can provide early intervention for those at high risk of dementia, including a world-first medicinal cannabis trial for those with early-stage Alzheimer’s disease. A/Prof Steiner has attracted >$15M AUD in grant funding, 20 awards and prizes, and has published >65 peer reviewed publications.